[PDF][PDF] How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance
AC Jaramillo, F Al Saig, J Cloos, G Jansen… - Cancer Drug Resist, 2018 - f.oaes.cc
Abstract P-glycoprotein (ABCB1), multidrug resistance protein-1 (ABCC1) and breast cancer
resistance protein (ABCG2) belong to the ATP-binding cassette (ABC) superfamily of …
resistance protein (ABCG2) belong to the ATP-binding cassette (ABC) superfamily of …
[HTML][HTML] Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells
AK Nanayakkara, CA Follit, G Chen, NS Williams… - Scientific reports, 2018 - nature.com
Overexpression of ATP-binding cassette (ABC) transporters is often linked to multidrug
resistance (MDR) in cancer chemotherapies. P-glycoprotein (P-gp) is one of the best studied …
resistance (MDR) in cancer chemotherapies. P-glycoprotein (P-gp) is one of the best studied …
Application of curcumin and its derivatives in tumor multidrug resistance
T Xu, P Guo, Y He, C Pi, Y Wang, X Feng… - Phytotherapy …, 2020 - Wiley Online Library
Malignant tumor endangers seriously the health of all mankind. Multidrug resistance (MDR)
is one of the main causes of clinical tumor chemotherapy failure. Curcumin (CUR) has not …
is one of the main causes of clinical tumor chemotherapy failure. Curcumin (CUR) has not …
MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp
C Lu, Z Shan, C Li, L Yang - Biomedicine & Pharmacotherapy, 2017 - Elsevier
Abstract Development of multiple drug resistance (MDR) to chemotherapy is the major
reason for the failure of gastric cancer (GC) treatment. P-glycoprotein (P-gp), which is …
reason for the failure of gastric cancer (GC) treatment. P-glycoprotein (P-gp), which is …
[HTML][HTML] Structure-based discovery of novel P-glycoprotein inhibitors targeting the nucleotide binding domains
L Moesgaard, ML Pedersen, C Uhd Nielsen… - Scientific Reports, 2023 - nature.com
Abstract P-glycoprotein (P-gp), a membrane transport protein overexpressed in certain drug-
resistant cancer cells, has been the target of numerous drug discovery projects aimed at …
resistant cancer cells, has been the target of numerous drug discovery projects aimed at …
[HTML][HTML] CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell …
L Norouzi-Barough, M Sarookhani… - Iranian journal of …, 2018 - ncbi.nlm.nih.gov
Objective (s): Multidrug resistance (MDR) is a major obstacle in the successful
chemotherapy of ovarian cancer. Inhibition of P-glycoprotein (P-gp), a member of ATP …
chemotherapy of ovarian cancer. Inhibition of P-glycoprotein (P-gp), a member of ATP …
Optimizing targeted inhibitors of P-glycoprotein using computational and structure-guided approaches
Overexpression of ABC transporters like P-glycoprotein (P-gp) has been correlated with
resistances in cancer chemotherapy. Intensive efforts to identify P-gp inhibitors for use in …
resistances in cancer chemotherapy. Intensive efforts to identify P-gp inhibitors for use in …
[HTML][HTML] Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT
R Li, C Wu, H Liang, Y Zhao… - International …, 2018 - spandidos-publications.com
The transcription factor twist family bHLH transcription factor 1 (TWIST), which is a member
of the basic helix-loop-helix class of proteins, is known to induce epithelial-mesenchymal …
of the basic helix-loop-helix class of proteins, is known to induce epithelial-mesenchymal …
[HTML][HTML] A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance
Multidrug resistance (MDR) to chemotherapeutic drugs remains one of the major
impediments to the treatment of cancer. Discovery and development of drugs that can …
impediments to the treatment of cancer. Discovery and development of drugs that can …
Nanodrugs based on co-delivery strategies to combat cisplatin resistance
Q Wang, H Li, T Wu, B Yu, H Cong, Y Shen - Journal of Controlled Release, 2024 - Elsevier
Cisplatin (CDDP), as a broad-spectrum anticancer drug, is able to bind to DNA and inhibit
cell division. Despite the widespread use of cisplatin since its discovery, cisplatin resistance …
cell division. Despite the widespread use of cisplatin since its discovery, cisplatin resistance …